ID

23714

Beskrivning

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00668642

Länk

https://clinicaltrials.gov/show/NCT00668642

Nyckelord

  1. 2017-07-11 2017-07-11 -
Uppladdad den

11 juli 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT00668642

Eligibility Prostate Cancer NCT00668642

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven prostate cancer
Beskrivning

ID.1

Datatyp

boolean

Alias
UMLS CUI [1]
C0007112
patients are hormone-naive
Beskrivning

ID.2

Datatyp

boolean

Alias
UMLS CUI [1]
C0019932
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
Beskrivning

ID.3

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1515985
UMLS CUI [1,2]
C1518041
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
Beskrivning

ID.4

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0376358
UMLS CUI [1,2]
C0027627
must have an intact prostate (no previous surgery or xrt)
Beskrivning

ID.5

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0543467
ecog performance status 0-2
Beskrivning

ID.6

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
recovery from any major infection or surgical procedure
Beskrivning

ID.7

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0543467
signed informed consent
Beskrivning

ID.8

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
known intolerance or allergy to dutasteride
Beskrivning

ID.9

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0754659
concomitant chemotherapy, biologic therapy, or xrt to prostate
Beskrivning

ID.10

Datatyp

boolean

Alias
UMLS CUI [1]
C1707479
bilateral orchiectomy
Beskrivning

ID.11

Datatyp

boolean

Alias
UMLS CUI [1]
C0194875
prior malignancy within 5 years of registration
Beskrivning

ID.12

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826

Similar models

Eligibility Prostate Cancer NCT00668642

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically proven prostate cancer
boolean
C0007112 (UMLS CUI [1])
ID.2
Item
patients are hormone-naive
boolean
C0019932 (UMLS CUI [1])
ID.3
Item
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
boolean
C1515985 (UMLS CUI [1,1])
C1518041 (UMLS CUI [1,2])
ID.4
Item
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
boolean
C0376358 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.5
Item
must have an intact prostate (no previous surgery or xrt)
boolean
C0543467 (UMLS CUI [1,1])
ID.6
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
ID.7
Item
recovery from any major infection or surgical procedure
boolean
C3714514 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
ID.8
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.9
Item
known intolerance or allergy to dutasteride
boolean
C0020517 (UMLS CUI [1,1])
C0754659 (UMLS CUI [1,2])
ID.10
Item
concomitant chemotherapy, biologic therapy, or xrt to prostate
boolean
C1707479 (UMLS CUI [1])
ID.11
Item
bilateral orchiectomy
boolean
C0194875 (UMLS CUI [1])
ID.12
Item
prior malignancy within 5 years of registration
boolean
C0006826 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial